AC
SYK icon

Abbrea Capital’s Stryker SYK Stock Holding History

Abbrea Capital’s Portfolio SYK Stock Details SYK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$2.71M Sell
7,950
-57
-0.7% -$19.3K 0.36% 58
2024
Q1 		$2.87M Hold
8,007
– – 0.38% 56
2023
Q4 		$2.4M Buy
8,007
+60
+0.8% +$16.8K 0.35% 65
2023
Q3 		$2.18M Buy
7,947
+62
+0.8% +$17.8K 0.35% 65
2023
Q2 		$2.41M Buy
7,885
+35
+0.4% +$10.1K 0.37% 59
2023
Q1 		$2.25M Hold
7,850
– – 0.38% 60
2022
Q4 		$1.93M Sell
7,850
-50
-0.6% -$11.3K 0.35% 69
2022
Q3 		$1.61M Sell
7,900
-133
-2% -$28K 0.3% 71
2022
Q2 		$1.6M Sell
8,033
-45
-0.6% -$10.6K 0.27% 84
2022
Q1 		$2.17M Buy
8,078
+60
+0.7% +$15.5K 0.3% 69
2021
Q4 		$2.15M Buy
8,018
+181
+2% +$47.5K 0.29% 74
2021
Q3 		$2.07M Buy
7,837
+90
+1% +$24.1K 0.31% 71
2021
Q2 		$2.02M Buy
7,747
+242
+3% +$61.9K 0.3% 73
2021
Q1 		$1.84M Sell
7,505
-55
-0.7% -$13.2K 0.3% 76
2020
Q4 		$1.86M Buy
7,560
+325
+4% +$73.6K 0.33% 70
2020
Q3 		$1.51M Sell
7,235
-95
-1% -$18.5K 0.32% 74
2020
Q2 		$1.32M Sell
7,330
-668
-8% -$123K 0.3% 75
2020
Q1 		$1.34M Buy
7,998
+85
+1% +$16.6K 0.36% 68
2019
Q4 		$1.67M Sell
7,913
-752
-9% -$156K 0.35% 67
2019
Q3 		$1.88M Buy
8,665
+30
+0.3% +$6.43K 0.44% 61
2019
Q2 		$1.78M Buy
8,635
+180
+2% +$34.4K 0.44% 60
2019
Q1 		$1.67M Hold
8,455
– – 0.48% 59
2018
Q4 		$1.33M Hold
8,455
– – 0.44% 62
2018
Q3 		$1.51M Sell
8,455
-200
-2% -$34.1K 0.44% 60
2018
Q2 		$1.47M Hold
8,655
– – 0.46% 57
2018
Q1 		$1.4M Buy
8,655
+5
+0.1% +$806 0.45% 58
2017
Q4 		$1.34M Sell
8,650
-115
-1% -$17.5K 0.46% 62
2017
Q3 		$1.25M Sell
8,765
-250
-3% -$35.8K 0.46% 63
2017
Q2 		$1.25M Buy
9,015
+25
+0.3% +$3.43K 0.5% 60
2017
Q1 		$1.19M Buy
8,990
+1,605
+22% +$203K 0.48% 62
2016
Q4 		$888K Buy
+7,385
New +$850K 0.42% 72

Other funds holding SYK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Abbrea Capital's SYK Position: Q2 2024 in Review

Abbrea Capital reduced its Stryker (SYK) stake by 0.71% in Q2 2024, selling an estimated $19.3K and leaving 7,950 shares worth $2.71M. The position accounts for 0.36% of the portfolio, ranked #58.

Abbrea Capital first reported a position in SYK in Q4 2016 and has held it in 31 quarters since. The position peaked at $2.87M in Q1 2024. 1,985 funds tracked by Wall St. Rank hold SYK as of Q2 2024.

  • Abbrea Capital held 7,950 shares of Stryker worth $2.71M as of Q2 2024.
  • Abbrea Capital sold 57 Stryker shares in Q2 2024, an estimated $19.3K.
  • Stryker made up 0.36% of Abbrea Capital's portfolio in Q2 2024, its #58 holding.
  • Abbrea Capital first reported a position in Stryker in Q4 2016 and has held it in 31 quarters since.
  • Abbrea Capital's Stryker position peaked at $2.87M in Q1 2024.
  • 1,985 funds tracked by Wall St. Rank held Stryker as of Q2 2024.

Based on Abbrea Capital's 13F filing for Q2 2024, filed 8 Aug 2024.